Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator

Science

Volumn 284, Issue 5414, 1999, Pages 647-650

  Kim, Yang Hee ^a,b   Park, June Hee ^a   Hong, Seung Hwan ^b   Koh, Jae Young ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; KAINIC ACID; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOT LYSIS; BRAIN CORTEX; BRAIN INJURY; CELL PROTECTION; CEREBROVASCULAR ACCIDENT; DRUG EFFECT; HIPPOCAMPUS; NERVE CELL EXCITABILITY; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

ANIMALS; CELL DEATH; CELLS, CULTURED; CEREBRAL CORTEX; CYTOPROTECTION; HIPPOCAMPUS; HUMANS; KAINIC ACID; MALE; MICE; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PLASMIN; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SEIZURES; TISSUE PLASMINOGEN ACTIVATOR; ZINC;

ANIMALIA;

EID: 0033597411     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.284.5414.647     Document Type: Article

References (42)

1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, N. Engl. J. Med. 333, 1581 (1995); J. A. Zivin, Drugs 54 (suppl. 3), 83 (1997); M. J. Alberts, Am. J. Cardiol. 28, 29D (1997).
2. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, N. Engl. J. Med. 333, 1581 (1995); J. A. Zivin, Drugs 54 (suppl. 3), 83 (1997); M. J. Alberts, Am. J. Cardiol. 28, 29D (1997).
3. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, N. Engl. J. Med. 333, 1581 (1995); J. A. Zivin, Drugs 54 (suppl. 3), 83 (1997); M. J. Alberts, Am. J. Cardiol. 28, 29D (1997).
4. Y. F. Wang et al., Nature Med. 4, 228 (1998); A. D. Rogove and S. E. Tsirka, Curr. Biol. 8, 19 (1998); S. E. Tsirka, A. D. Rogove, T. H. Bugge, J. L. Degen, S. Strickland, J. Neurosci. 17, 543 (1997); S. E. Tsirka, J. Mol. Med. 75, 341 (1997); -, A. D. Rogove, S. Strickland, Nature 384, 123 (1996).
5. Y. F. Wang et al., Nature Med. 4, 228 (1998); A. D. Rogove and S. E. Tsirka, Curr. Biol. 8, 19 (1998); S. E. Tsirka, A. D. Rogove, T. H. Bugge, J. L. Degen, S. Strickland, J. Neurosci. 17, 543 (1997); S. E. Tsirka, J. Mol. Med. 75, 341 (1997); -, A. D. Rogove, S. Strickland, Nature 384, 123 (1996).
6. Y. F. Wang et al., Nature Med. 4, 228 (1998); A. D. Rogove and S. E. Tsirka, Curr. Biol. 8, 19 (1998); S. E. Tsirka, A. D. Rogove, T. H. Bugge, J. L. Degen, S. Strickland, J. Neurosci. 17, 543 (1997); S. E. Tsirka, J. Mol. Med. 75, 341 (1997); -, A. D. Rogove, S. Strickland, Nature 384, 123 (1996).
7. Y. F. Wang et al., Nature Med. 4, 228 (1998); A. D. Rogove and S. E. Tsirka, Curr. Biol. 8, 19 (1998); S. E. Tsirka, A. D. Rogove, T. H. Bugge, J. L. Degen, S. Strickland, J. Neurosci. 17, 543 (1997); S. E. Tsirka, J. Mol. Med. 75, 341 (1997); -, A. D. Rogove, S. Strickland, Nature 384, 123 (1996).
8. Y. F. Wang et al., Nature Med. 4, 228 (1998); A. D. Rogove and S. E. Tsirka, Curr. Biol. 8, 19 (1998); S. E. Tsirka, A. D. Rogove, T. H. Bugge, J. L. Degen, S. Strickland, J. Neurosci. 17, 543 (1997); S. E. Tsirka, J. Mol. Med. 75, 341 (1997); -, A. D. Rogove, S. Strickland, Nature 384, 123 (1996).
9. Z. L. Chen and S. Strickland, Cell 91, 917 (1997).
10. S. M. Rothman and J. W. Olney, Ann. Neurol. 19, 105 (1986); D. W. Choi and S. M. Rothman, Annu. Rev. Neurosci. 13, 171 (1990).
11. S. M. Rothman and J. W. Olney, Ann. Neurol. 19, 105 (1986); D. W. Choi and S. M. Rothman, Annu. Rev. Neurosci. 13, 171 (1990).
12. D. W. Choi and J. Y. Koh, Annu. Rev. Neurosci. 21, 347 (1998).
13. C. J. Frederickson, M. D. Hernandez, J. F. McGinty, Brain Res. 480, 317 (1989); N. Tonder, F. F. Johansen, C. J. Frederickson, J. Zimmer, N. H. Diemer, Neurosci. Lett. 109, 247 (1990).
14. C. J. Frederickson, M. D. Hernandez, J. F. McGinty, Brain Res. 480, 317 (1989); N. Tonder, F. F. Johansen, C. J. Frederickson, J. Zimmer, N. H. Diemer, Neurosci. Lett. 109, 247 (1990).
15. J. Y. Koh et al., Science 272, 1013 (1996), S. W. Suh, J. Y. Koh, D. W. Choi, Soc. Neurosci. Abstr. 22, 2101 (1996).
16. J. Y. Koh et al., Science 272, 1013 (1996), S. W. Suh, J. Y. Koh, D. W. Choi, Soc. Neurosci. Abstr. 22, 2101 (1996).
17. Y. H. Kim, E. Y. Kim, B. J. Gwag, S. Sohn, J. Y. Koh, Neuroscience 89, 175 (1999); D. W. Choi, M. Yokoyama, J. Koh, ibid. 24, 67 (1988).
18. Y. H. Kim, E. Y. Kim, B. J. Gwag, S. Sohn, J. Y. Koh, Neuroscience 89, 175 (1999); D. W. Choi, M. Yokoyama, J. Koh, ibid. 24, 67 (1988).
19. 2 incubator in MEM until the next day, when the assessment for cell injury was made. Human recombinant tPA (Boehringer Ingelheim and Sigma) was dissolved in distilled water at 1 mg/ml, stored at -70°C, and diluted to final concentrations immediately before use.
20. J. Y. Koh and D. W. Choi, J. Neurosci. Methods 20, 83 (1987). In most experiments, overall cell injury was quantitatively assessed by measurement of LDH released by damaged or destroyed cells into the bathing medium 24 hours after exposure to drugs. Each LDH value was scaled to the maximal neuronal LDH release (= 100) after 24 hours of exposure to 300 μM NMDA in sister cultures, where near-complete neuronal death with no glial damage occurs. Numbers greater than 100 usually indicate additional astroglial cell injury.
21. J. H. Weiss, D. M. Hartley, J. Y. Koh, D. W. Choi, Neuron 10, 43 (1993); J. Y. Koh and D. W. Choi, Neuroscience 60, 1049 (1994); S. L. Sensi et al., J. Neurosci. 17, 9554 (1997).
22. J. H. Weiss, D. M. Hartley, J. Y. Koh, D. W. Choi, Neuron 10, 43 (1993); J. Y. Koh and D. W. Choi, Neuroscience 60, 1049 (1994); S. L. Sensi et al., J. Neurosci. 17, 9554 (1997).
23. J. H. Weiss, D. M. Hartley, J. Y. Koh, D. W. Choi, Neuron 10, 43 (1993); J. Y. Koh and D. W. Choi, Neuroscience 60, 1049 (1994); S. L. Sensi et al., J. Neurosci. 17, 9554 (1997).
24. C. J. Frederickson, E. J. Kasarskis, D. Ringo, R. E. Frederickson, J. Neurosci. Methods 20, 91 (1987). After zinc exposure, cultures were washed three times with HBSS and exposed to 4.5 μM TSQ solution. After 90 s, cultures were washed and examined under a fluorescence microscope (excitation 355 to 375 nm, dichroic 380 nm, barrier 520 nm) and photographed.
25. H. S. Chow, J. J. Lynch III, K. Rose, D. W. Choi, Brain Res. 639, 102 (1994); B. J. Gwag et al., Neuroreport 7, 93 (1995).
26. H. S. Chow, J. J. Lynch III, K. Rose, D. W. Choi, Brain Res. 639, 102 (1994); B. J. Gwag et al., Neuroreport 7, 93 (1995).
27. J. Y. Koh et al., Exp. Neurol. 135, 153 (1995); Y. H. Ahn, Y. H. Kim, S. H. Hong, J. Y. Koh, ibid. 154, 47 (1998).
28. J. Y. Koh et al., Exp. Neurol. 135, 153 (1995); Y. H. Ahn, Y. H. Kim, S. H. Hong, J. Y. Koh, ibid. 154, 47 (1998).
29. H. Ohkawa, N. Ohishi, K. Yagi, Anal. Biochem. 95, 351 (1979); L. J. S. Greenlund, T. L. Deckwerth, E. M. Johnson Jr., Neuron 14, 303 (1995). The extent of intracellutar free radical generation was visualized using the fluorescent probe 2,7-dichlorofluorescein diacetate (DCF, Molecular Probes). Cells were incubated for 30 min in the presence of DCF (4 μg/ml) and washed three times with Eagle's MEM (Earle's salts, supplied glutamine-free). Cultured cells were observed and photographed under the fluorescence microscope.
30. H. Ohkawa, N. Ohishi, K. Yagi, Anal. Biochem. 95, 351 (1979); L. J. S. Greenlund, T. L. Deckwerth, E. M. Johnson Jr., Neuron 14, 303 (1995). The extent of intracellutar free radical generation was visualized using the fluorescent probe 2,7-dichlorofluorescein diacetate (DCF, Molecular Probes). Cells were incubated for 30 min in the presence of DCF (4 μg/ml) and washed three times with Eagle's MEM (Earle's salts, supplied glutamine-free). Cultured cells were observed and photographed under the fluorescence microscope.
31. H. R. Lijnen and D. Collen, Thromb. Haemostasis 74, 387 (1995).
32. D. Lawrence, L. Strandberg, T. Grundstrom, T. Ny, Eur. J. Biochem. 186, 533 (1989); E. L. Madison et al., Proc. Natl. Acad. Sci. U.S.A. 87, 3530 (1990).
33. D. Lawrence, L. Strandberg, T. Grundstrom, T. Ny, Eur. J. Biochem. 186, 533 (1989); E. L. Madison et al., Proc. Natl. Acad. Sci. U.S.A. 87, 3530 (1990).
34. V. V. Novokhatny, K. C. Ingham, L. V. Medved, J. Biol. Chem. 266, 12994 (1991).
35. T. H. Welling, T. S. Huber, L. M. Messina, J. C. Stanley, J. Surg. Res. 66, 36 (1996).
36. Male adult Sprague-Dawley rats (250 to 300 g) were used for experiments. The Animal Welfare Guidelines of University of Ulsan College of Medicine were followed. Under stereotactic guidance and halothane anesthesia, one group was injected into lateral ventricles with 3 μl of saline alone (icv saline group, n = 3), and another group with 3 μl of tPA (1 mg/ml) in saline (icv tPA group, n = 3). The final group received injection of tPA (3 mg/kg) into the tail veins (iv tPA group, n = 3). Anesthesia was discontinued immediately after the injections. After 30 min, rats were intraperitoneally injected with kainate (10 mg/kg). Three hours after the kainate injection, seizures were halted by intraperitoneally injecting sodium diphenylhydantoin (50 mg/kg).
37. A. Whitelaw, M. C. Mowinckel, U. Abildgaard, Acta Paediatr. 84, 933 (1995).
38. D. Lekieffre, J. Benavides, B. Scatton, J. P. Nowicki, Brain Res. 776, 88 (1997).
39. X. Zhang, D. L. Gelowitz, C. T. Lai, A. A. Boulton, P. H. Yu, Eur. J. Neurosci. 9, 760 (1997). Severity of seizures was scored for 3 hours after kainate injection. Staring, freezing, and mouth/facial twitchings were scored as 1, wet dog shakes as 2, forelimb clonus and head nodding as 3, rearing as 4, rearing and falling as 5, and jumping and circling as 6. Scores at various time points after the kainate injections were averaged and compared with one another by two-tailed t tests. No difference in seizure severity was seen between conditions (p > 0.1) (Fig. 4A).
40. Twenty-four hours after kainate injection, brains were harvested, stained with cresyl violet or acid fuchsin (7), and examined under the microscope. No hemorrhage was seen in any specimen. Neuronal cell death in the hippocampus (CA1-4) was quantified by counting acid fuchsin-positive neurons in three brain sections, 10 μm thick and 800 μm apart, starting at 3.5 mm from bregma. Numbers obtained by two independent evaluators, who were blind to the experimental conditions, were averaged and statistically compared with one another using analysis of variance (ANOVA) with post hoc Student-Newman-Keuls test.
41. Z. Qian, M. E. Gilbert, M. A. Colicos, E. R. Kandel, D. Kuhl, Nature 361, 453 (1993).
42. Supported by Creative Research Initiatives of the Korean Ministry of Science and Technology (J.Y.K.).